Lentigo bụ obere ntụpọ pigmented na akpụkpọ ahụ nke nwere akụkụ akọwapụtara nke ọma. Lentigos bụ nsogbu na akpụkpọ ahụ metụtara ịka nká na ikpughe na radieshon ultraviolet sitere na anyanwụ. Ha dị n'ebe anwụ na-anọkarị, ọkachasị aka, ihu, ubu, ogwe aka na ọkpọiso, na akpụkpọ isi ma ọ bụrụ nkwọcha.
N'ọtụtụ ọnọdụ, lentigo enweghị ihe iyi egwu ma ọ chọghị ọgwụgwọ ọ bụla, ọ bụ ezie na a mara ha mgbe ụfọdụ ka ọ na-ekpuchi nchọpụta nke ọrịa cancer anụ ahụ. Otú ọ dị, n'agbanyeghị na ọ bụ ọnọdụ adịghị mma na-eyi ndụ egwu, a na-ewere lentigos mgbe ụfọdụ dị ka ihe na-adịghị mma ma wepụ ya.
Ndị ọrịa 12 nwetara ọgwụgwọ site na iji laser low‑fluence QS Nd:YAG, sitere na oge 5 ruo 12 (pulse duration of 5 to 10 nanoseconds, and an 8 mm spot size, and a fluence of 0.8 to 2.0 J/cm²). Iji ọgwụgwọ laser ugboro ugboro low‑fluence 1064 Nd:YAG nwere ike ịbụ nhọrọ dị mma ma dị irè maka senile lentigo. All 12 patients were treated in 5 to 12 sessions with low-fluence QS Nd:YAG laser, pulse duration of 5∼10 nsec, spot size of 8 mm, and fluence of 0.8∼2.0 J/cm2. Repetitive low fluence 1064 Nd:YAG laser treatment may be an effective and safe optional modality for senile lentigo.
A na-ahụkarị nsogbu pigmentation na nlekọta mbụ. Ụdị ọnọdụ akpụkpọ ahụ na-agba ọchịchịrị gụnyere post-inflammatory hyperpigmentation, melasma, sun spots, freckles, and café au lait spots. Pigmentation problems are often noticed in primary care. Typical types of darkening skin conditions include post-inflammatory hyperpigmentation, melasma, sun spots, freckles, and café au lait spots.
N'ọtụtụ ọnọdụ, lentigo enweghị ihe iyi egwu ma ọ chọghị ọgwụgwọ ọ bụla, ọ bụ ezie na a mara ha mgbe ụfọdụ ka ọ na-ekpuchi nchọpụta nke ọrịa cancer anụ ahụ. Otú ọ dị, n'agbanyeghị na ọ bụ ọnọdụ adịghị mma na-eyi ndụ egwu, a na-ewere lentigos mgbe ụfọdụ dị ka ihe na-adịghị mma ma wepụ ya.
○ Ọgwụgwọ
#QS532 laser